Varicose Veins Treatment Market Gains Momentum with Minimally Invasive Procedures - Persistence Market Research

The varicose veins treatment market is witnessing significant growth, driven by a combination of lifestyle-related factors and technological advancements. Varicose veins, which result from weakened or damaged vein walls and valves, are becoming increasingly prevalent due to sedentary lifestyles, obesity, and aging populations. The global market is projected to expand from US$828.6 million in 2024 to US$1,322.1 million by 2031, registering a CAGR of 6.9% over the forecast period. This growth is fueled by both cosmetic and medical considerations, with patients seeking minimally invasive procedures to address both health and aesthetic concerns.

Minimally invasive procedures, including endovenous laser therapy (EVLT), radiofrequency ablation (RFA), and sclerotherapy, have revolutionized the treatment landscape by offering effective, low-risk, and outpatient-compatible solutions. Among treatment types, sclerotherapy dominates the market, accounting for approximately 73% of the market share due to its convenience, low complication rates, and rapid recovery. Hospitals remain the leading end-user segment, contributing 60% of the market share in 2024, as they provide advanced diagnostic tools, multidisciplinary care, and access to complex procedures. Geographically, North America leads the global market with a 46% share, attributed to its robust healthcare infrastructure, high patient awareness, and preference for cosmetic treatments.

Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/34797

Key Highlights from the Report

• Growing demand for minimally invasive procedures such as EVLT, RFA, and sclerotherapy drives the market growth.
• Sclerotherapy varicose veins treatment to account for the highest market share of 73%.
• Aging populations contributing to a rising number of varicose vein cases globally.
• Hospitals to dominate the market, accumulating 60% of the market share in 2024.
• North America holds the largest market share due to advanced healthcare infrastructure of the region.
• Rising focus on cosmetic treatments and early-stage varicose vein interventions are key market driving elements.

Market Segmentation

The varicose veins treatment market can be segmented based on treatment type, end-user, and product offerings. Treatment types include endovenous ablation, sclerotherapy, and surgical ligation, with sclerotherapy leading due to its advantages such as minimal scarring, low bruising, and outpatient feasibility. Endovenous procedures like EVLT and RFA are gaining traction because they offer targeted treatment with shorter recovery times, fewer complications, and improved patient outcomes.

End-users of varicose veins treatments are primarily hospitals, vein clinics, and ambulatory care centers. Hospitals dominate due to their comprehensive medical infrastructure, availability of specialists, and capability to handle complex cases. Vein clinics and ambulatory centers are increasingly important for treating less severe cases or offering outpatient services that allow patients to avoid hospitalization. With advancements in minimally invasive technologies, outpatient centers are poised to capture a growing segment of the market, especially in regions with rising awareness and limited hospital access.

Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/varicose-veins-treatment-market.asp

Regional Insights

Regionally, North America leads the global market, driven by high patient awareness, robust healthcare systems, and strong adoption of cosmetic procedures. The U.S., in particular, has developed clear clinical care guidelines through the Society for Vascular Surgery and the American Venous Forum, which enhance treatment accessibility and insurance coverage for eligible patients. Europe follows closely, with increasing demand for minimally invasive procedures and the presence of specialized vascular clinics.

Asia Pacific represents an emerging growth market, as rising healthcare awareness, improving medical infrastructure, and expanding insurance coverage boost adoption. Countries such as China and India are witnessing increased investments in vein treatment technologies and outpatient centers. Meanwhile, regions like Latin America and the Middle East & Africa are gradually expanding their markets, primarily due to growing urban populations and rising interest in cosmetic procedures.

Market Drivers

The growth of the varicose veins treatment market is primarily driven by the rising prevalence of lifestyle-related risk factors, including obesity, prolonged sitting or standing, and aging populations. Sedentary work environments, combined with increasing rates of overweight individuals, are contributing to poor blood circulation and higher incidence of venous insufficiency. As awareness about varicose veins and associated complications grows, more patients are seeking early intervention, boosting demand for both surgical and non-surgical treatments.

Another key driver is technological advancement in minimally invasive procedures. Endovenous laser therapy, radiofrequency ablation, and sclerotherapy offer patients effective treatment with minimal downtime, reduced scarring, and low risk of complications. These procedures can often be performed in outpatient settings, making them more convenient and cost-effective. The refinement of these techniques, coupled with their increasing success rates, has encouraged widespread adoption among healthcare providers and patients, significantly propelling market growth.

Market Restraints

Despite robust growth, the market faces challenges, including high treatment costs and limited insurance coverage. Many minimally invasive procedures, while effective, remain expensive, and insurance providers often classify varicose vein treatments as cosmetic unless medically necessary. This limits accessibility for patients, especially in developing regions or lower-income groups.

Additionally, lack of awareness in emerging markets restrains market growth. In several developing countries, varicose veins are often perceived as a cosmetic issue rather than a medical condition, leading to delayed treatment. Combined with a shortage of specialized healthcare providers and clinics, these factors create significant barriers to adoption and limit market expansion in these regions.

Market Opportunities

The varicose veins treatment market presents significant opportunities in the expansion of non-invasive and outpatient procedures. Outpatient clinics and ambulatory care centers are increasingly able to deliver high-quality treatments without hospitalization, offering faster recovery and lower costs. Innovations in endovenous laser therapy, radiofrequency ablation, and sclerotherapy are expected to further enhance success rates, efficiency, and patient satisfaction.

Emerging markets, particularly in Asia Pacific, provide untapped potential due to rising healthcare awareness, urbanization, and improved access to modern treatment facilities. The growing emphasis on preventive healthcare, coupled with increasing insurance coverage for varicose vein treatments, creates favorable conditions for market expansion. As technology continues to advance, non-invasive treatment options are likely to attract a larger patient base, driving long-term growth and profitability.

Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/34797

Company Insights

The varicose veins treatment market is highly competitive, with key players including:

• AngioDynamics
• Medtronic
• Teleflex Incorporated
• Sciton, Inc.
• Dornier Medtech
• Merit Medical Systems
• Alma Lasers
• Biolitec AG
• Boston Scientific Corporation

Varicose Veins Treatment Market Segmentation

By Treatment

Endovenous Ablation
Sclerotherapy
Surgical Ligation

By End User

Vein Clinics
Hospitals
Ambulatory Care Unit

By Region

North America
Latin America
Europe
South Asia & Oceania
East Asia
The Middle East & Africa

Recent developments highlight ongoing innovation in the market:

June 2022: VVT Medical entered into a distribution arrangement with Getz Healthcare in the Asia Pacific region to expand the reach of varicose vein treatment devices.

April 2022: I-VASC, an Italian medical device company, secured a EUR 1.8 million Series A investment for the launch of its VELEX device, enhancing minimally invasive treatment options.

Conclusion

The varicose veins treatment market is poised for sustained growth, driven by increasing prevalence of venous disorders, advancements in minimally invasive procedures, and rising patient awareness. Sclerotherapy remains the leading treatment, while hospitals continue to dominate as the primary end-user segment due to their advanced infrastructure and comprehensive care capabilities. North America leads the global market, with emerging regions such as Asia Pacific presenting new growth opportunities.

Despite challenges related to high treatment costs and limited awareness in developing regions, the market benefits from opportunities in outpatient and non-invasive procedures, technological innovations, and expanding insurance coverage. As the global population continues to age and lifestyles become more sedentary, demand for effective varicose vein treatments is expected to rise, making the market increasingly dynamic and attractive for healthcare providers and investors alike.

Read More Related Reports:

North America Toxicology Laboratories Market https://www.persistencemarketresearch.com/market-research/north-america-toxicology-laboratories-market.asp
North America Scar Treatment Market https://www.persistencemarketresearch.com/market-research/north-america-scar-treatment-market.asp
Irritable Bowel Syndrome Treatment Market https://www.persistencemarketresearch.com/market-research/irritable-bowel-syndrome-treatment-market.asp
Life Science Market https://www.persistencemarketresearch.com/market-research/life-science-market.asp

Contact Us:

Persistence Market Research
Second Floor, 150 Fleet Street, London, EC4A 2DQ, United Kingdom
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.